FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/3/2026
CorMedix (NASDAQ: CRMD) reported Q2 EPS of ($0.19), $0.02 better than the analyst estimate of ($0.21).
For earnings history and earnings-related data on CorMedix (CRMD) click here.
... More
